GEN also decreased the over‐production of pro‐inflammatory cytokines TNF‐α, IL‐1β and IL‐6, proved GEN could reduce the inflammation during the progress of NAFLD. This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.